Lung squamous cell carcinoma metastasizing to the nasopharynx following bronchoscopy intervention therapies: a case report

World Journal of Surgical Oncology

Case Report

Mei Jin¹  Jian-bin Hu²  Xiao-nan Sun²  En-guo Chen³ 

[1] Department of Pathology, Sir Run Run Shaw Hospital of Zhejiang University Medical School, No. 3 Qingchun East Road, 310016, Hangzhou, Zhejiang Province, China;Department of Radiation Oncology, Sir Run Run Shaw Hospital of Zhejiang University Medical School, No. 3 Qingchun East Road, 310016, Hangzhou, Zhejiang Province, China;Department of Respiratory Medicine, Sir Run Run Shaw Hospital of Zhejiang University Medical School, No. 3 Qingchun East Road, 310016, Hangzhou, Zhejiang Province, China;

关键词: Lung cancer;    Metastasis;    Nasopharynx;    Squamous cell carcinoma;   

DOI  :  10.1186/1477-7819-12-68

 received in 2013-09-17, accepted in 2014-03-15,  发布年份 2014

来源: Springer

【 摘 要 】

Metastatic carcinoma to the nasopharynx is extremely rare, and few cases have been reported in the literature. In the present report, we describe the case of a patient with a mass in the nasopharynx found by bronchoscopy. Our patient was a 61-year-old man receiving multiple bronchoscopy intervention therapies for advanced lung squamous cell carcinoma (SCC), which was histopathologically confirmed. The SCC metastasized to the nasopharynx following the bronchoscopy intervention therapies. The lesion was considered metastatic from lung cancer on the basis of clinical and histological clues. The exact mechanism of lung cancer metastasis to the nasopharynx in this case remains unclear because either implantation or hematogenous and lymphatic spread is possible. A thorough head and neck examination should be undertaken during bronchoscopic evaluation, especially in patients receiving bronchoscopy intervention therapies. The early detection of a silent nasopharyngeal metastasis is important to choosing from among the multiple treatment options available.

【 授权许可】

Unknown   
© Hu et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.